These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21988016)

  • 1. The regulation of pharmacy ownership in Australia: the potential impact of changes to the health landscape.
    Hattingh HL
    J Law Med; 2011 Sep; 19(1):147-54. PubMed ID: 21988016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corporatisation of Community Pharmacy and the Constitutional Prohibition of Civil Conscription for Medical Service Providers.
    Yazidjoglou C; Faunce T
    J Law Med; 2016; 24(1):41-60. PubMed ID: 30136773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact on community pharmacy of the changing generic medicine substitution landscape.
    Hattingh HL; Maganlal S; King MA
    J Law Med; 2010 May; 17(5):761-71. PubMed ID: 20552939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the impact of evolving health policy on independent pharmacy ownership in England.
    Gidman W
    Pharm World Sci; 2010 Aug; 32(4):488-95. PubMed ID: 20454857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in public satisfaction with community pharmacy services in Tartu, Estonia, between 1993 and 2005.
    Volmer D; Bell JS; Janno R; Raal A; Hamilton DD; Airaksinen MS
    Res Social Adm Pharm; 2009 Dec; 5(4):337-46. PubMed ID: 19962677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia.
    Wibowo Y; Berbatis C; Joyce A; Sunderland VB
    Rural Remote Health; 2010; 10(3):1400. PubMed ID: 20684656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provision of primary care to patients with chronic cough in the community pharmacy setting.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
    Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-prescription medicines: current issues in Australian community pharmacy.
    Tan AC; Emmerton L
    Int J Pharm Pract; 2009 Aug; 17(4):207-13. PubMed ID: 20217945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
    Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceutical care in community pharmacies: practice and research in Estonia.
    Volmer D; Vendla K; Vetka A; Bell JS; Hamilton D
    Ann Pharmacother; 2008 Jul; 42(7):1104-11. PubMed ID: 18577761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Governance and the pharmaceutical workforce in England.
    Noyce P
    Res Social Adm Pharm; 2006 Sep; 2(3):408-19. PubMed ID: 17138523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacy services in Portugal.
    Costa S; Santos C; Silveira J
    Ann Pharmacother; 2006 Dec; 40(12):2228-34. PubMed ID: 17148652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market dynamics of community pharmacies in Minnesota.
    Schommer JC; Singh RL; Cline RR; Hadsall RS
    Res Social Adm Pharm; 2006 Sep; 2(3):347-58. PubMed ID: 17138519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of ownership type on role orientation, role affinity, and role conflict among community pharmacy managers and owners in Canada.
    Perepelkin J; Dobson RT
    Res Social Adm Pharm; 2010 Dec; 6(4):280-92. PubMed ID: 21111386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with epilepsy's perception on community pharmacist's current and potential role in their care.
    McAuley JW; Miller MA; Klatte E; Shneker BF
    Epilepsy Behav; 2009 Jan; 14(1):141-5. PubMed ID: 18984065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.